US Stocks
/
Pasithea Therapeutics Corp. Share Price

Pasithea Therapeutics Corp. Share Price

NASDAQ: KTTA | Micro Cap
$0.46
+$0.02 (3.71%) Last updated on 10 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pasithea Therapeutics Corp. Stock Performance

Open
$0.45
Prev. Close
$0.45
Circuit Range
N/A
Day Range
$0.45 - $0.46
Year Range
$0.29 - $2.06
Volume
500
Average Traded
$0.46

Pasithea Therapeutics Corp. Share Price Today

As of 11 October 2026, Pasithea Therapeutics Corp.'s share price is $0.46. The stock opened at $0.45, compared to its previous close of $0.45. During today's trading session, Pasithea Therapeutics Corp.'s share price traded between $0.45 and $0.46, with an average price of $0.46. Over the past 52 weeks, the stock has recorded a high of $2.06 and a low of $0.29. In terms of performance, Pasithea Therapeutics Corp.'s share price has declined by 34.62% over the last six months and is down 42.37% on a year-on-year basis.

Pasithea Therapeutics Corp. Share Price Chart

$0.45$0.46
L
Show Current Price
H

Pasithea Therapeutics Corp. Stock Fundamentals & Key Indicators

Market Cap
$3.25M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$0.00
Return On Equity (TTM)
-42.72%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-73.36%

Pasithea Therapeutics Corp. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.04-$10.11-$2.87-$5.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-232.57%71.61%-83.62%

Pasithea Therapeutics Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.94-$15.96-$13.90-$20.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.49%12.91%-46.98%

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Pasithea Therapeutics Corp. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.46
$0.46
-6.68%
Sep 2026
$0.55
$0.49
-10.99%
Aug 2026
$0.45
$0.56
+19.35%
Jul 2026
$0.59
$0.47
-9.36%
Jun 2026
$0.71
$0.51
-27.85%
May 2026
$0.72
$0.71
+0.71%
Apr 2026
$0.65
$0.71
-5.87%
Mar 2026
$0.83
$0.75
-8.42%
Feb 2026
$0.85
$0.82
-4.99%
Jan 2026
$1.23
$0.86
-33.69%
Dec 2025
$1.25
$1.30
-10.96%
Nov 2025
$0.82
$1.46
+82.27%

KTTA Share Price FAQs

What is Pasithea Therapeutics Corp. share price today?

chevron-up
Pasithea Therapeutics Corp. share price today is $0.46 as on October 10, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of Pasithea Therapeutics Corp. stock?

chevron-up
The 52 week high of Pasithea Therapeutics Corp. stock is $2.06, while the 52 week low is $0.29 as of 10 Oct '26.

What is KTTA's market capitalisation today?

chevron-up
KTTA market capitalisation is $3.25M as of October 11, 2026, at 2:07 am IST.

What is KTTA's net income for the last quarter?

chevron-up
KTTA's net income for the last quarter is -5.27B USD.

What is the 5 year returns of KTTA?

chevron-up
The 5 year returns of KTTA is -99.18% as on 10 Oct '26.

What is the high & low stock price of KTTA today?

chevron-up
KTTA stock price hit a high of $0.46 and low of $0.45 as of 10 Oct '26.

Can I buy KTTA shares in India?

chevron-up
Yes. You can buy KTTA in India by opening an international trading account.